In this study, using a cohort of 68 PDAC patients, we found that C/EBPβ and C/EBPγ expression in primary tumor cells can partially compensate for the frequent loss of tumor cell C/EBPδ in order to improve patient survival. This evidence concerns the gene CEBPD and neoplasm.